First, we evaluated progression to HCC in 2969 HCV-infected patients from the BioBank Japan (19), using an intronic IFNL4 marker rs12979860, which is completely linked with rs368234815 in Asians (r2 = 1.0). This evidence concerns the gene IFNL4 and hepatocellular carcinoma.